| Entry |
|
|---|
| Name |
Vecuronium bromide (JAN/USP/INN);
Norcuron (TN) |
|---|
| Product |
|
|---|
| Generic |
VECURONIUM BROMIDE (Eugia US LLC), VECURONIUM BROMIDE (Eugia US LLC), VECURONIUM BROMIDE (Fresenius Kabi USA), VECURONIUM BROMIDE (Fresenius Kabi USA), VECURONIUM BROMIDE (Gland Pharma Limited), VECURONIUM BROMIDE (HF Acquisition Co LLC), VECURONIUM BROMIDE (Hikma Pharmaceuticals USA), VECURONIUM BROMIDE (Hospira), VECURONIUM BROMIDE (Mylan Institutional LLC), VECURONIUM BROMIDE (Phlow Corp.), VECURONIUM BROMIDE (Sagent Pharmaceuticals), VECURONIUM BROMIDE (Sun Pharmaceutical Industries) |
|---|
| Formula |
C34H57N2O4. Br
|
|---|
| Exact mass |
636.3502
|
|---|
| Mol weight |
637.73
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
Musculo-skeletal system agent
DG02029 Muscle relaxant
DG01696 Peripherally-acting muscle relaxant
DG03117 Nondepolarizing neuromuscular blocking agent
DG01742 Quaternary ammonium compound type muscle relaxant
|
|---|
| Remark |
| Product (DG00770): | D00767<US> |
|
|---|
| Efficacy |
Skeletal muscle relaxant, Neuromuscular blocking agent, Muscarinic acetylcholine receptor antagonist |
|---|
| Comment |
Quaternary ammonium compound
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
|
|---|
| Interaction |
|
|---|
| Structure map |
| map07221 | Nicotinic cholinergic receptor antagonists |
|
|---|
| Other map |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
M MUSCULO-SKELETAL SYSTEM
M03 MUSCLE RELAXANTS
M03A MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS
M03AC Other quaternary ammonium compounds
M03AC03 Vecuronium
D00767 Vecuronium bromide (JAN/USP/INN) <US>
Drug groups [BR:br08330]
Musculo-skeletal system agent
DG02029 Muscle relaxant
DG01696 Peripherally-acting muscle relaxant
DG03117 Nondepolarizing neuromuscular blocking agent
DG00770 Vecuronium
D00767 Vecuronium bromide
DG01742 Quaternary ammonium compound type muscle relaxant
DG00770 Vecuronium
D00767 Vecuronium bromide
Target-based classification of drugs [BR:br08310]
Ion channels
Ligand-gated ion channels
Acetylcholine (nicotinic)
CHRN (neuronal type)
D00767 Vecuronium bromide (JAN/USP/INN) <US>
Drug groups [BR:br08330]
Musculo-skeletal system agent
DG02029 Muscle relaxant
DG01696 Peripherally-acting muscle relaxant
DG03117 Nondepolarizing neuromuscular blocking agent
DG00770 Vecuronium
DG01742 Quaternary ammonium compound type muscle relaxant
DG00770 Vecuronium
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 41
1 C1z C 20.4325 -15.3326
2 C1y C 20.4151 -16.7073
3 C1y C 21.6333 -14.6597
4 C1x C 19.2549 -14.6365
5 C1a C 20.4211 -13.9577
6 C1y C 19.2319 -17.3802
7 C1x C 22.7993 -16.7362
8 C1y C 22.8109 -15.3615
9 O7a O 21.6217 -12.9366
10 C1x C 18.0658 -15.3151
11 C1y C 18.0543 -16.6841
12 C1x C 19.2319 -18.7492
13 N2y N 24.0060 -14.6886 #+
14 C7a C 20.4325 -12.2520
15 C1z C 16.8596 -17.3629
16 C1x C 18.0427 -19.4337
17 C1x C 25.1951 -15.3731
18 C1x C 24.0060 -13.3196
19 C1a C 24.0001 -16.0633
20 C1a C 19.2433 -12.9366
21 O6a O 20.4211 -10.8773
22 C1y C 16.8536 -18.7376
23 C1x C 15.6701 -16.6783
24 C1a C 16.8476 -15.9939
25 C1x C 26.3843 -14.6886
26 C1x C 25.2009 -12.6350
27 C1x C 15.6701 -19.4278
28 C1y C 14.4809 -17.3629
29 C1x C 26.3843 -13.3196
30 C1y C 14.4809 -18.7376
31 N1y N 13.2975 -16.6841
32 O7a O 13.2860 -19.4164
33 C1x C 13.2975 -15.3093
34 C1x C 12.1025 -17.3686
35 C7a C 13.2860 -20.7852
36 C1x C 12.1025 -14.6248
37 C1x C 10.9134 -16.6841
38 C1a C 12.0967 -21.4640
39 O6a O 14.4751 -21.4640
40 C1x C 10.9134 -15.3093
41 X Br 23.9581 -17.9438 #-
BOND 45
1 1 2 1
2 1 3 1
3 1 4 1
4 1 5 1 #Up
5 2 6 1
6 2 7 1
7 3 8 1
8 3 9 1 #Up
9 4 10 1
10 6 11 1
11 6 12 1
12 8 13 1 #Up
13 9 14 1
14 11 15 1
15 12 16 1
16 13 17 1
17 13 18 1
18 13 19 1
19 14 20 1
20 14 21 2
21 15 22 1
22 15 23 1
23 15 24 1 #Up
24 17 25 1
25 18 26 1
26 22 27 1
27 23 28 1
28 25 29 1
29 27 30 1
30 28 31 1 #Up
31 30 32 1 #Down
32 31 33 1
33 31 34 1
34 32 35 1
35 33 36 1
36 34 37 1
37 35 38 1
38 35 39 2
39 36 40 1
40 7 8 1
41 10 11 1
42 16 22 1
43 26 29 1
44 28 30 1
45 37 40 1
|
|---|
